Vivolux AB
Records under this name other than the patents Vivolux AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 3 of 3 · Back to Vivolux AB
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,856,511 | Protease deubiquitinating inhibitor screening Lapsed on the fee record Ended Jan 2, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 2, 2026 | From the USPTO record |
| US 9,562,046 | Means and method for treating solid tumors Lapsed on the fee record Ended Feb 7, 2025 · From the USPTO record | Lapsed on the fee record | Ended Feb 7, 2025 | From the USPTO record |
| US 9,221,761 | Method for inhibition of deubiquitinating activity Lapsed on the fee record Ended Dec 29, 2023 · From the USPTO record | Lapsed on the fee record | Ended Dec 29, 2023 | From the USPTO record |